Wm Smit - Department of Medical Oncology, Medical Spectrum Twente

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 22 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML Patients

C Kockerols, P J M Valk, P Hogenbirk, I Geelen,N M A Blijlevens, J,M Hoogendoorn, S Kersting,S K Klein,L G M Daenen, M Donker,P A W Te Boekhorst, K-S G Jie, M Corsten, M J Cruijsen, H Levenga,W M Smit,M-D Levin,E de Jongh, S de Jonge, A J Vlot, M F Durian, M Mohlmann, T J Wustman, R Blommers,P E Westerweel, Collaborating Authors

European journal of haematologyno. 5 (2025): 900-907

Cited0Views0WOSBibtex

P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION

C. C. Kockerols,J. J. Janssen, N. M. Blijlevens,S. K. Klein, L. G. van Hussen-Daenen, G. N. van Gorkom,W. M. Smit,P. van Balen,B. J. Biemond, M. J. Cruijsen, M. F. Corsten,P. A. te Boekhorst,H. R. Koene, G. L. van Sluis, J. J. Cornelissen,P. E. Westerweel

HemaSphere (2022): 604-605

Cited1Views0Bibtex

High-dose Chemotherapy (HDCT) with Hematopoietic Stem Cell Transplantation (HSCT) in High-Risk Breast Cancer (BC) Patients with ≥4 Involved Axillary Lymph Nodes (ALN): 20-Year Follow-Up of a Randomized Phase 3 Study, : Proffered Paper (oral Presentation) 187O

Tessa G. Steenbruggen,Lars C. Steggink, C Seynaeve, J. van der Hoeven, Maartje J. Hooning,Agnes Jager,IR Konings,Judith R. Kroep,WM Smit,Vivianne C. G. Tjan‐Heijnen,Elsken van der Wall,AD Bins,SC Linn,Michael Schaapveld,FE van Leeuwen,Carolina P. Schröder,Harm van Tinteren, Elisabeth G.E. de Vries, Gabe S. Sonke, Jourik A. Gietema

openalex（2018）

Cited0Views0Bibtex

Phase I and Pharmacological Trial of Lapatinib in Combination with Gemcitabine in Patients with Advanced Breast Cancer

R. van der Noll,W. M. Smit,A. N. M. Wymenga,D. S. Boss, M. Grob,A. D. R. Huitema,H. Rosing,M. M. Tibben, M. Keessen, H. Rehorst,J. H. Beijnen,J. H. M. Schellens

Investigational New Drugs（2015）

Cited10Views0WOSBibtex

A Randomized Phase II Study Investigating the Addition of the Specific COX-2 Inhibitor Celecoxib to Docetaxel Plus Carboplatin As First-Line Chemotherapy for Stage IC to IV Epithelial Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinomas: the DoCaCel Study

A. K. L. Reyners,L. de Munck,F. L. G. Erdkamp,W. M. Smit,K. Hoekman,R. I. Lalisang,H. de Graaf,A. N. M. Wymenga,M. Polee,H. Hollema,M. A. T. M. van Vugt,M. Schaapveld,P. H. B. Willemse

Annals of Oncology（2012）

Cited39Views0WOSBibtex

Lapatinib: Clinical Benefit in Patients with HER 2-Positive Advanced Breast Cancer

J. R. Kroep,S. C. Linn,E. Boven,H. J. Bloemendal,J. Baas,I. A. M. Mandjes,J. van den Bosch,W. M. Smit,H. de Graaf,C. P. Schroder, G. J. Vermeulen,W. C. J. Hop,J. W. R. Nortier

PubMedno. 9 (2010): 371-6

Cited35Views0WOSBibtex

A Phase Ii Study Evaluating the Safety and Efficacy of Patupilone in Patients with Platinum Refractory/Resistant Ovarian, Primary Fallopian, or Peritoneal Cancer

W. M. Smit,J. Sufliarsky,T. L. Werner,D. Dizon,M. Wagnerova,H. W. Hirte, R. Delaney,J. Li, D. Weber,J. H. Schellens

JOURNAL OF CLINICAL ONCOLOGY（2009）

Cited29Views0Bibtex

Adding the Specific COX-2 Inhibitor Celecoxib to Docetaxel Plus Carboplatin in First Line for Stage IC-IV Epithelial Ovarian Cancer: A Randomized Phase II Study

A. Reyners,W. M. Smit,M. S. Schaapveld,K. Hoekman,F. Erdkamp,R. Lalisang,H. Graaf,M. A. Wymenga,M. Polee,P. H. Willemse

Journal of clinical oncology（2009）

Cited25Views0Bibtex

Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients

P Nieboer,E G E de Vries,N H Mulder,S Rodenhuis,M Bontenbal,E van der Wall,Q G van Hoesel,W M Smit,P Hupperets,E E Voest,M A Nooij,H M Boezen,W T A van der Graaf

Bone Marrow Transplantationno. 7 (2008): 475-481

Cited9Views0WOSNATUREBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn